Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
An open-label, multi-center, 6-week, sequential cohort study designed to determine the safety
and tolerability of two dose ranges of BL-1020 in hospitalized subjects with chronic
schizophrenia or schizo-affective disorder